Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The FGF/FGFR Signalling Pathway: a Novel Therapeutic Target in Liposarcomas

NCT03303885 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT03303885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03303885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The FGF/FGFR Signalling Pathway: a Novel Therapeutic Target in Liposarcomas
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Observational
Overall status
Completed
Start date
October 1, 2017
Completion date
March 29, 2019
Enrollment
421 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liposarcoma